Synergistic Action of Target Site Mutations and Detoxification Enzymes Reveals Vulnerabilities in Malaria Mosquitoes' Insecticide Resistance

Background
Insecticide-treated nets and indoor residual spraying are critical interventions for controlling malaria-transmitting mosquitoes. However, the effectiveness of these methods is being undermined by the rapid spread of insecticide resistance in mosquito populations exposed to the same class of insecticides. Pyrethroid insecticides, which have been widely used for a long time, are facing an urgent need for resistance management.
Previous studies have primarily analyzed target-site resistance, which involves changes in the insecticide's target site within the mosquito's nervous system, and metabolic resistance, which involves the detoxification of the insecticide, as separate mechanisms. For example, amino acid substitutions in ion channel proteins can disrupt insecticide binding, while increased expression of detoxification enzymes, including cytochrome P450s, can reduce the concentration of the insecticide within the mosquito. However, a key challenge is that the presence of a single mutation or enzyme level alone cannot accurately predict the actual survival rate. Field mosquito populations often carry multiple resistance factors simultaneously, and the genetic interactions between these factors can lead to non-linear effects on insecticide efficacy.
Key Findings
This study, published in PNAS, Volume 123, Issue 30, 2026, focuses on the fact that mutations in insecticide target genes and detoxification enzymes do not act independently. The researchers compared the resistance-related genotypes and detoxification capabilities of malaria-transmitting mosquitoes, and found that the combination of these two defense mechanisms can have a synergistic effect, exceeding the sum of their individual effects.
Changes in the target protein reduce the likelihood of the insecticide binding to its target site, while detoxification enzymes reduce the amount of insecticide that reaches the target site. The study suggests that when these two mechanisms occur together in the same individual, even limited levels of resistance factors can lead to high survival rates. This implies that existing surveillance methods, which only assess the presence of specific resistance alleles or measure detoxification enzyme activity, may underestimate the actual level of resistance in the field.
Conversely, this interdependence creates opportunities for intervention. Inhibiting detoxification reactions or applying insecticides that are effective against one of the two mechanisms may disrupt the resistance, which is amplified when both mechanisms are present. The novelty of this research lies in its shift from identifying individual resistance genes to proposing combinations of genotypes and metabolic phenotypes as targets for control.
Significance and Outlook
These findings provide further evidence that mosquito resistance should be viewed as an interacting network rather than a single-gene trait. In resistance monitoring, combining target-site mutation detection with measurements of detoxification enzymes such as cytochrome P450, glutathione S-transferase, and esterase can more accurately estimate the actual risk of control failure.
Industrially, this research has the potential to be applied in the development of insecticide and metabolic inhibitor combinations, the alternating use of insecticides with different modes of action, and the development of insecticide-treated nets tailored to specific regional genotypes. However, the magnitude of gene-gene interactions may vary depending on the mosquito species and population, insecticide concentration, and environmental conditions. The vulnerability identified in the laboratory needs to be validated in field settings, and the effectiveness of combination strategies in delaying the emergence of new resistance needs to be assessed through long-term field trials.
Proceedings of the National Academy of Sciences, Volume 123, Issue 30, July 2026. Significance: Managing the increasing problem of insecticide resistance in malaria vectors requires a detailed understanding of its genetic basis. Although several genes have been associated with resistance, little is known about their complex interactions ...
In malaria-endemic regions, control agencies can investigate the detoxification enzyme activity of the same mosquito population in addition to detecting target site mutations before deciding on control measures. For example, in areas with high levels of both target mutations and cytochrome P450 dependence, insecticide-treated nets containing cytochrome P450 inhibitors or indoor residual spraying with non-pyrethroid insecticides could be prioritized.
Insecticide developers can evaluate candidate compounds using mosquito strains that replicate multiple resistance mechanisms rather than testing with strains containing only individual resistance factors. However, the toxicity, cost, residual activity, and impact on non-target organisms of metabolic inhibitors must also be considered, and actual application should be preceded by regional resistance data and field efficacy testing.